About Clarapath
Clarapath is a Healthcare company based in New York (United States) founded in 2014. Standalone pathology clinical laboratory services are provided. Clarapath has raised $72.16 million across 3 funding rounds from investors including Ochsner, Northwell and Mayo Clinic. Clarapath has completed 1 acquisition, including Crosscope. Clarapath offers products and services including SectionStar and Consulting. Its focus areas include Clinical Laboratories. Its legal entity is Clarapath Inc.
Company details
Clarapath was founded in 2014 and is headquartered in New York, United States. Operations focus on standalone pathology clinical laboratories within the healthcare sector. Services encompass diagnostic testing and analysis for pathology needs, supporting medical professionals and institutions. The company maintains its domain at clarapath.com, serving regional and potentially broader markets through specialized lab infrastructure and protocols.
- Headquarters New York, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website clarapath.com
- Social LinkedIn
- Legal Name Clarapath Inc
Products & Services of Clarapath
Clarapath offers a comprehensive portfolio of products and services, including SectionStar and Consulting.
An automated system for sectioning and slide preparation that is utilized in histology laboratories to enhance processing
Services that are offered to healthcare professionals for improving laboratory operations and workflow efficiency
Funding Insights of Clarapath
Clarapath has successfully raised a total of $72.16M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $36 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $72.16M
- Total Rounds 3
- Last Round Series B — $36M
- First Round $4.16M
(Nov 2019)
- Investors Count 8
All 3 funding rounds of Clarapath with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2024 | $36M | Series B | – | Northwell | |
| Nov 2021 | $32M | Series B | – | Northwell, P5 Health Ventures | |
| Nov 2019 | $4.16M | Series A | – | – | – |
8 investors in total: 8 institutional.
Investors in Clarapath
Clarapath has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Ochsner, Northwell and Mayo Clinic.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| cuvcfund.com | ||||
East Post Road Ventures is focused on healthcare innovation investments. | eprventures.com | White Plains, United States | ||
Early-stage investments in US tech and life sciences are targeted. | p5hv.com | Westport, United States | ||
A chain of multispecialty hospitals is operated in New York. | 1997 | northwell.edu | New York, United States | |
General medical clinics are operated throughout the United States. | 1864 | mayoclinic.org | United States | |
Healthcare services, research, education, and community support are provided. | 1942 | ochsner.org | United States | |
Offers investment opportunities in wealth management and healthcare innovations for clients. | 2019 | the4100group.com | Lansing, United States | |
Provides online wealth planning and financial management services. | epiphroncapitalgroup.com | North Bergen, United States |
Investor details for Clarapath
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Clarapath
20 people are tracked at Clarapath (6 in leadership, 10 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Matt Claster | VP Strategy & Business Development | Leadership |
Eric Feinstein | President & CEO | Leadership |
Carolyn Woodberry | Chief of Staff | Leadership |
Aaron Ames | VP, Engineering | Leadership |
Nick Diprimo | Director Of Mechanical R&d And Production | Leadership |
Cristian Grigoras | Director Of Materials Science | Leadership |
David Eigen | Director | Board & advisors |
Daniel T. Barry | Advisor | Board & advisors |
Patrik Dahlen | Advisor | Board & advisors |
Charles Cantor | Advisor | Board & advisors |
Sherry Liu | Director | Board & advisors |
Robert Stallone | Director | Board & advisors |
Michael Shelanski | Advisor | Board & advisors |
Partha Mitra | Director | Board & advisors |
James Crawford | Director | Board & advisors |
Yukako Yagi | Advisor | Board & advisors |
Steven L. Smith | Principal Optical Engineer | Team |
Thomas Crow | Mechanical Engineer | Team |
Anthony Chauca | Mechanical Engineer | Team |
Stacy Mendez | Mechanical Engineer | Team |
Complete people profiles for Clarapath
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Clarapath
Clarapath has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Crosscope.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
A discussion platform is provided for pathologists and healthcare professionals. | crosscope.com | Paris, France | 2019 | Feb 2023 | •••• |
Complete acquisition details for Clarapath
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Clarapath
4 dated milestones of Clarapath across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Clarapath is founded.
- Funding First funding round of $4.2M.
- Acquisition Acquires Crosscope.
- Funding Latest funding round, Series B, of $36.0M.
Web traffic of Clarapath
The website of Clarapath (clarapath.com) receives about 6.5K visits a month.
- Monthly visits6.5K
▲ 16.9% vs previous month
Top companies in Diagnostics Laboratories
2 companies that operate in the same segment as Clarapath (Diagnostics Laboratories) in United States, ranked by their profile score on The Company Check.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Clarapath
Clarapath was founded in 2014 and raised its 1st funding round 5 years after it was founded.
Clarapath is headquartered in New York, United States. It is registered at New York, New York, United States.
Clarapath is a funded company, having raised a total of $72.16M across 3 funding rounds to date. The company's 1st funding round was a Series A of $4.16M, raised on Nov 2019.
Clarapath was founded in 2014 and is headquartered in New York, United States. Operations focus on standalone pathology clinical laboratories within the healthcare sector. Services encompass diagnostic testing and analysis for pathology needs, supporting medical professionals and institutions. The company maintains its domain at clarapath.com, serving regional and potentially broader markets through specialized lab infrastructure and protocols.
Clarapath offers SectionStar and Consulting.
Clarapath has made 1 acquisition, including Crosscope.
Clarapath has 8 investors. Key investors include Ochsner, Northwell, Mayo Clinic, CU Healthcare Innovation Fund, and East Post Road Ventures.
Clarapath operates through Clarapath Inc.